7 results

Fotolia_68767205_Subscription_Monthly_M
Value

Posted on 15.07.2019

Medical technology and the new European institutions

Medical technology needs to communicate better about its value. Some people think it is the same as pharmaceutical healthcare. It is not. Medical technology has a different innovation approach, timeline and model. The European Union needs to communicate better about its value. Some people think it is the same as the national entities that make […]

By Eric Thépaut Senior Vice President and President, EMEA - Boston Scientific

Fotolia_228889174_Subscription_Monthly_M
Regulation

Posted on 13.05.2019

Notified Bodies are becoming a regulatory bottleneck

The new EU regulations on medical devices and in vitro diagnostics (IVDs) share a laudable aim: They seek to modernise the regulatory framework and enhance transparency. The goal, shared by all stakeholders, is to enhance patient safety without harming innovations that improve patient outcomes. However, with these two regulations coming into force by May 2020 […]

By Fabien Roy Partner - Hogan Lovells

Fotolia_228889174_Subscription_Monthly_M
Regulation

Posted on 08.11.2018

The fog of war: crunch time in the regulatory cycle

As I followed the 1,075 km cycling route starting at the Belgium coast and ending in Basel, Switzerland, along the Western Front line of the First World War, I began to consider the plight of soldiers and generals a century ago. For military leaders, it was impossible to have an overview of what was happening […]

By Ronald Boumans Senior Regulatory Consultant at Emergo

Fotolia_209648487_Subscription_Monthly_M
Value

Posted on 06.11.2018

Celebrating 30 years of ABHI

As ABHI celebrates its 30th anniversary today, Peter Ellingworth, Chief Executive of the association discusses the past, present and future.  1.  In the 30-year history of ABHI, what have been the biggest changes? Our industry has changed significantly over the last 30 years, from being simply product based, to delivering value-based service solutions and increasingly […]

By Peter Ellingworth Chief Executive of the Association of British Healthcare Industries (ABHI)

Fotolia_219619515_Subscription_Monthly_M
Regulation

Posted on 14.09.2018

What does Brexit mean for Notified Bodies?

With 45% of devices accessing the EU via UK NBs, what would be the impact of a so-called “hard Brexit?” The political landscape is far from clear. However, BSI would concur with the recent MHRA  paper as we fully anticipate remaining part of the EU system for the long term. We also agree that nothing […]

By Gary Slack Senior Vice President Global Medical Devices, BSI Group

New Medical Device Regulation – an obstacle to progress
Regulation

Posted on 11.06.2018

New Medical Device Regulation – an obstacle to progress

On May 25th, 2017, a new era began. The date marks the beginning of the Medical Device Regulation, the MDR in short. It provides a new framework for the certification of medical devices in Europe and is supposed to increase the transparency of the approval and application of medical devices, as well as to improve […]

By Dr. Meinrad Lugan Member of the Management Board, B. Braun Melsungen AG

Fotolia_193493508_Subscription_Monthly_M
Regulation

Posted on 05.03.2018

Invest! Lead! Engage! Let’s Make Europe’s New Regulatory System Work

We are now over 15% of the transition period of the new European IVD Regulation (IVDR) and over 25% of the Medical Devices Regulation (MDR) transition. That said, transitioning to the new system comes with highly-ambitious timelines, and success will require great effort, by industry and authorities alike. Last week, at the Association of the […]

By Oliver Bisazza Chief Executive Officer, MedTech Europe